How Does Glutathione Work in Our Body
Glucagon-like peptide-1 (GLP-1) agonist therapies are increasingly being used for type 2 diabetes and obesity, but evidence now shows they also reduce inflammation across multiple organs through mechanisms related and unrelated to weight-loss-driven metabolic improvements
Encourages a healthy gut lining & nutrient absorption
Our free 3-minute DiabeSCORE quiz analyses your symptoms, lifestyle, and risk factors to give you a personalised metabolic health score and tells you exactly where your GLP-1 system may need support
The absolute difference in liver fat content [LFC] was 4.7% (95% CI from 6.7 to 2.7), with a relative decrease in LFC from baseline of 35.9% and 28.4% for the two individual dosages ( p 40%, renal death, new onset of macroalbuminuria) strongly favored tirzepatide (HR 0.58, 95% CI from 0.43 to 0.80, p = 0.0008)